LIR Life Sciences Corp., formerly Blackbird Critical Metals Corp., is the legal successor to the claimed CSE:BBRD issuer after a November 2025 fundamental change. It now develops transdermal therapies under CSE:SKNY; its Tyee and Muskox mineral interests are fully impaired and inactive.
- Country
- Canada